On 8/9/19, CEL-SCI stated they are still waiting on the 298th event to occur!!!!


CASH CASH BABY

The 6/30/19 10Q detailed we have over $12M in cash to work with due to the high amounts of warrants converted!


***NO CASH RAISE/DILUTION UNTIL AT LEAST FEB 2020!***

Take Me To Cash Page

BLACKROCK ADDS 1.3M SHARES

BLACKROCK ADDED 1.3M SHARES LAST QUARTER PER THEIR 13F. THEY NOW HAVE OVER 1.8M SHARES.

STILL WAITING ON #298 AS OF 8/9/19

 CEL-SCI updated their Fact Sheet and states: "we are still waiting on the required events."  

LEAKS?

Some of you say there should be "leaks" of how the Trial is coming....So here is one.


From the 10/2/2015 Minutes of Aintree HaNC Patient Research Forum, a CT Site: 


 "...Observed effects of the drug have shown significant reduction in size of tumour." 


Read Aintree Minutes

HELLO RUSSELL 2000!

Big Day on 6/28! Over 3M Shares put into the Russell 2000 and related indexes for 1 YEAR!!


 PR from CEL-SCI ABOUT JOINING THE R2K INDEX HERE


There was massive Index buying afterhours on June 28th and over 3M shares are now locked down for 1 year.  They are now effectively removed from the float.


This decreases the supply.  What happens to prices when supply decreases?


Ergomed Insider Transactions

 Dr Miroslav Reljanovic, Executive Chairman of the Company, purchased 200K shares ($775K USD) on 6/24.  Add this to the recent purchases by the COO and CFO brings the total to over $1.2M USD of Insider transactions in the past weeks.


Insider transactions details HERE


For a Deep Dive on the Ergomed and CEL-SCI relationship, please read this Article HERE

CEL-SCI IS HIRING!!!!!!!

Why is a Biotech with limited cash resources hiring 3 operational positions? Why would they incur the costs to hire, train and pay new employees this late?

Why do they think they need OPERATIONAL positions?


This is not normal...This is BULLISH!!!!!


Career Page

Our 15 Minutes of Fame

Aren't we something?  Watch this video talking all about this site!  

Watch Video

SeekingAlpha Articles are Great!

With much effort, our team has published the following articles on SeekingAlpha: 


 


THESE ARE MUST READS!

****BIG INSIDER BUYS AT MARKET PRICE****

On  6/3,  Geert  bought  MORE!  He  bought  another  $25K


On 5/7,  Geert "purchased another $100,000 worth of restricted CEL-SCI stock at $6.86 directly from the Company at the full market price. Several others from our senior management team and one member of the Board of Directors have joined  Geert and purchased another $110,000 worth of CEL-SCI stock on the same terms. "


Furthermore, on 5/21 Peter Young bought another $10K on the open market.

THE IDMC NEWS WAS HUGE

On 3/29/19, Cel-Sci released a PR stating that the IDMC has done their recent interim review and they made the following recommendation:


"continue the trial until the appropriate number of events have occurred."


PRESS RELEASE HERE


This is a big fucking deal!  At this point in the 8 year study, they have about 95% of all the data.  They would know if the study was futile or not.  If it was futile, they would have shut it down.


In the last 2 weeks the IDMC has shut down 3 trials for FUTILITY.  CVM just had the IDMC review their Phase III study for futility and recommended the trial should continue.  The 3 PRs link below are from the 3 recent trials that were just shut down:


 PRESS RELEASE HERE 

 

PRESS RELEASE HERE


PRESS RELEASE HERE


More about IDMC

Full-Scale Manufacturing Facility Tour

 CEL-SCI operates its own 73,000 sq. ft. manufacturing facility and produces Multikine for its clinical trials. About $100M was spent on the manufacturing plant, development and validation. 


Manufacturing in-house helps them protect their IP and allows for more control when working with the FDA and other regulators to secure approval of Multikine. 


Read All About the Recent Tour to the Facility HERE